Key result
Hydroquinazoline derivatives act as novel Natriuretic Peptide Receptor 1 (NPR1) activators, which play a critical role in lowering blood pressure and blood volume.
Hydroquinazoline derivatives are identified as novel Natriuretic Peptide Receptor 1 (NPR1) activators with potential applications in lowering blood pressure and blood volume.
This patent highlights hydroquinazoline compounds and their pharmaceutically acceptable salts, as well as compositions and methods of preparation. The compounds in this invention were evaluated for their potency on Natriuretic Peptide Receptor 1 (NPR1), a receptor guanylate cyclase known to play a critical role in lowering blood pressure and blood volume.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question. Hydroquinazoline derivatives act as novel Natriuretic Peptide Receptor 1 (NPR1) activators, which play a critical role in lowering blood pressure and blood volume.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: